239 related articles for article (PubMed ID: 32386797)
1. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
[TBL] [Abstract][Full Text] [Related]
2. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
Chen J; Yang Y; Liu Y; Kan H
World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
[TBL] [Abstract][Full Text] [Related]
3. A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes.
Powers BD; Rothermel LD; Fleming JB; Strosberg JR; Anaya DA
J Gastrointest Surg; 2020 Dec; 24(12):2773-2779. PubMed ID: 31754990
[TBL] [Abstract][Full Text] [Related]
4. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
Lin J; Huang H
Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of systemic immune-inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection.
Chen G; Liu L; Tan C; Tan Q; Chen Y; An X; Liu X; Wang X
Cancer Med; 2024 Apr; 13(7):e7114. PubMed ID: 38553949
[TBL] [Abstract][Full Text] [Related]
6. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract][Full Text] [Related]
7. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
8. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
9. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
Ye H; Xu HL; Shen Q; Zheng Q; Chen P
J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
[TBL] [Abstract][Full Text] [Related]
10. Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis.
Sonbol MB; Mazza GL; Mi L; Oliver T; Starr J; Gudmundsdottir H; Cleary SP; Hobday T; Halfdanarson TR
Oncologist; 2022 Jul; 27(7):573-578. PubMed ID: 35348774
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors.
Shi M; Zhou B
Cancer Control; 2021; 28():1073274820986827. PubMed ID: 33491476
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors.
Sharpe SM; In H; Winchester DJ; Talamonti MS; Baker MS
J Gastrointest Surg; 2015 Jan; 19(1):117-23; discussion 123. PubMed ID: 25155459
[TBL] [Abstract][Full Text] [Related]
14. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
[TBL] [Abstract][Full Text] [Related]
15. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States.
Liu X; Chen B; Chen J; Su Z; Sun S
J Endocrinol Invest; 2023 Jul; 46(7):1373-1384. PubMed ID: 36522587
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of multidetector CT features in predicting overall survival outcomes in patients with pancreatic neuroendocrine tumors.
Yang B; Chen HY; Zhang XY; Pan Y; Lu YF; Yu RS
Eur J Radiol; 2020 Mar; 124():108847. PubMed ID: 31991300
[TBL] [Abstract][Full Text] [Related]
17. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Tumor Prognosis of Pancreatic Neuroendocrine Tumors Using Image, Surgical and Pathologic Findings.
Chen F; Huang Y; Chen C; Zhang Y; Zhang Y; Wan R; Xu M
Neuro Endocrinol Lett; 2023 Oct; 44(7):453-464. PubMed ID: 37874552
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
[TBL] [Abstract][Full Text] [Related]
20. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
